Cataflam and Protonix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cataflam (diclofenac potassium) and Protonix (pantoprazole sodium). Common drug interactions include renal cancer among females and injury among males.

The phase IV clinical study analyzes what interactions people have when they take Cataflam and Protonix. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.

On Jul, 12, 2026

33 people who take Cataflam and Protonix together, and have interactions are studied.

Cataflam and Protonix drug interactions.

What are the common drug interactions of Cataflam and Protonix, by gender? *:

female:

Renal cancer (cancer of kidney)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Subdural haemorrhage (bleeding between the skull and the surface of the brain)
Upper respiratory tract infection
Vomiting
Wound infection
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Cardiogenic shock (inadequate circulation of blood)
Device related infection
Dyspnoea (difficult or laboured respiration)

male:

Injury
Adnexa uteri mass (ovarian cysts)
Decreased interest
Depression
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Dyspepsia (indigestion)
Ear pain
Exostosis (formation of new bone on the surface of a bone)
Fatigue (feeling of tiredness)

What are the common drug interactions of Cataflam and Protonix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain upper
Cholecystitis chronic (long lasting infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Injury

20-29:

Electrocardiogram qt prolonged
Electrocardiogram repolarisation abnormality
Electrocardiogram st-t change
Gangrene (body tissue dies)
Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs)
Hypoxia (low oxygen in tissues)
Injury
Mitral valve incompetence (inefficient heart valve)
Myalgia (muscle pain)
Peripheral vascular disorder

30-39:

Drug ineffective
Ear discomfort
Ear pain
Nausea (feeling of having an urge to vomit)
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

40-49:

Chronic kidney disease
Productive cough

50-59:

Blindness unilateral
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Asthma
Autoimmune hepatitis
Haematocrit decreased
Haematoma (collection of blood outside the blood vessels)
Haemoglobin decreased
Injection site haematoma (localized swelling filled with blood at injection site)

60+:

n/a

What are the existing conditions these people have? *

High Blood Pressure: 9 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 18.18%
Inflammation: 4 people, 12.12%
Sleep Disorder: 3 people, 9.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 9.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 9.09%
Neuropathy Peripheral (surface nerve damage): 3 people, 9.09%
High Blood Cholesterol: 3 people, 9.09%
Dyspnea (difficult or laboured breathing): 2 people, 6.06%
Bone Disorder: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Cataflam and Protonix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously